Treatment of rheumatoid arthritis with biological agents-as a typical and common immune-mediated inflammatory disease

Tsutomu Takeuchi

研究成果: Review article査読

6 被引用数 (Scopus)

抄録

Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.

本文言語English
ページ(範囲)600-608
ページ数9
ジャーナルProceedings of the Japan Academy Series B: Physical and Biological Sciences
93
8
DOI
出版ステータスPublished - 2017

ASJC Scopus subject areas

  • 農業および生物科学(全般)
  • 物理学および天文学(全般)

フィンガープリント

「Treatment of rheumatoid arthritis with biological agents-as a typical and common immune-mediated inflammatory disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル